Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Microbot Medical Inc

Healthcare US MBOT

1.84USD
-0.12(6.12%)

Last update at 2026-06-05T20:22:00Z

Day Range

1.821.93
LowHigh

52 Week Range

0.863.66
LowHigh

Fundamentals

  • Previous Close 1.96
  • Market Cap14.61M
  • Volume857392
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-9.74900M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.86

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -13.16800M -11.31300M -9.16900M -7.24700M -7.24000M
Minority interest - - - - -
Net income 104.83M -11.26900M -9.24900M -7.35000M -7.24000M
Selling general administrative 5.42M 5.09M 5.56M 4.03M 4.50M
Selling and marketing expenses - - - - 0.02M
Gross profit - - - - 0.00000M
Reconciled depreciation 0.10M 0.08M 0.07M 0.08M 0.05M
Ebit -13.28100M -11.35700M -9.08900M -7.24000M -7.25000M
Ebitda -13.23800M -11.28100M -9.02100M -7.15600M -7.19600M
Depreciation and amortization 0.04M 0.08M 0.07M 0.08M 0.05M
Non operating income net other - - - - -
Operating income -13.28100M -11.35700M -9.08900M -7.24000M 7.24M
Other operating expenses 13.28M 11.36M 9.09M 7.24M 7.24M
Interest expense -131.28100M 0.04M 0.08M 0.10M 0.00000M
Tax provision - - - - -
Interest income 0.05M - - 0.10M 0.02M
Net interest income 0.05M 0.04M -0.08000M -0.10300M -0.00200M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -118.00000M -0.04400M 0.08M 0.10M -14.48400M
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 13.28M 11.36M 9.09M 7.24M 7.24M
Cost of revenue - - - - 0.00000M
Total other income expense net 0.11M 0.04M -0.08000M -0.00700M 0.00600M
Discontinued operations - - - - -
Net income from continuing ops -13.16800M -11.31300M -9.16900M -7.34300M 7.24M
Net income applicable to common shares -13.16800M -11.31300M -9.16900M -7.24700M 7.24M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 8.33M 9.54M 16.77M 26.28M 37.13M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.15M 0.61M 0.39M 0.27M 7.17M
Total liab 3.83M 2.25M 2.39M 1.97M 5.59M
Total stockholder equity 4.50M 7.29M 14.38M 24.31M 31.54M
Deferred long term liab - - - - -
Other current liab 3.24M 1.67M 0.40M -0.13100M 0.61M
Common stock 0.12M 0.08M 0.07M 0.07M 0.07M
Capital stock 0.12M 0.08M 0.07M 0.07M 0.07M
Retained earnings -79.50100M -68.76100M -55.59300M -44.28000M -35.11100M
Other liab - - - - -
Good will - - - - -
Other assets 0.00000M - - - -
Cash 2.52M 2.44M 13.49M 19.65M 28.77M
Cash and equivalents - - - - -
Total current liabilities 3.79M 2.07M 1.98M 1.34M 4.83M
Current deferred revenue - - 1.03M 1.01M 3.79M
Net debt -2.28600M -1.98000M -12.81300M -18.83700M -27.86800M
Short term debt 0.19M 0.28M 0.28M 0.19M 0.14M
Short long term debt - - - - -
Short long term debt total 0.23M 0.46M 0.68M 0.81M 0.90M
Other stockholder equity 83.88M 75.97M 69.90M 68.52M 66.58M
Property plant equipment - 0.72M 0.89M 1.03M 0.23M
Total current assets 7.92M 8.81M 15.88M 25.25M 35.94M
Long term investments - - - - -
Net tangible assets - 7.29M 14.38M 24.31M 31.54M
Short term investments 3.92M 5.76M 2.00M 5.00M 2.52M
Net receivables 1.33M 0.10M 0.17M 0.34M 0.10M
Long term debt - - - - -
Inventory - -0.10300M -0.17400M -0.00500M -2.62200M
Accounts payable 0.36M 0.12M 0.28M 0.28M 0.28M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -0.14500M
Additional paid in capital - - - - -
Common stock total equity - - - 0.00007M 0.07M
Preferred stock total equity - - - - -
Retained earnings total equity - - - -44.28000M -35.11100M
Treasury stock - - - - -3.37500M
Accumulated amortization - - - - -
Non currrent assets other -0.00000M - - 0.00500M 0.96M
Deferred long term asset charges - - - - -
Non current assets total 0.41M 0.72M 0.89M 1.03M 1.19M
Capital lease obligations 0.23M 0.46M 0.68M 0.81M 0.90M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -3.83600M 3.20M -2.76800M -2.49600M -0.22300M
Change to liabilities -0.24100M 0.32M -0.24000M -0.14000M 0.46M
Total cashflows from investing activities - 3.20M -2.76800M -2.45300M -0.22300M
Net borrowings - - - - -0.01800M
Total cash from financing activities 4.32M 4.32M -3.37500M 36.77M -0.01800M
Change to operating activities 0.01M 0.18M 0.22M -0.12600M -0.04000M
Net income -13.16800M -11.31300M -9.16900M -7.24700M -7.24000M
Change in cash -11.06100M -6.15400M -13.39500M 27.87M -5.55100M
Begin period cash flow 13.58M 19.73M 33.13M 5.26M 10.81M
End period cash flow 2.52M 13.58M 19.73M 33.13M 5.26M
Total cash from operating activities -11.54900M -9.35400M -7.25200M -6.45100M -5.31000M
Issuance of capital stock 4.32M - 0.00000M 36.77M 0.00000M
Depreciation 0.10M 0.08M 0.07M 0.08M 0.05M
Other cashflows from investing activities - - - 0.26M -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - -0.04000M
Sale purchase of stock - - - 36.77M -
Other cashflows from financing activities -3.83600M 3.20M -3.37500M -2.45300M -0.01800M
Change to netincome - 1.39M 1.87M 1.00M 1.38M
Capital expenditures 0.08M 0.07M 0.09M 0.22M 0.22M
Change receivables - - - - -0.04000M
Cash flows other operating - - 0.15M -0.15100M 0.07M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - -13.39500M 27.87M -5.55100M
Change in working capital -0.22800M 0.50M -0.01800M -0.26600M 0.42M
Stock based compensation 1.75M 1.39M 1.94M 1.10M 1.40M
Other non cash items -0.00700M 10.81M -0.07000M -0.02500M 0.07M
Free cash flow -11.63300M -9.42300M -7.34300M -6.66700M -5.53300M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
MBOT
Microbot Medical Inc		 -0.12 6.12% 1.84 - - - 3.23 -0.8364
ISRG
Intuitive Surgical Inc		 3.24 0.77% 422.06 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme		 -5.1675 2.52% 200.15 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -3.16 3.08% 99.50 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 1.60 1.07% 151.16 25.56 12.48 2.59 1.76 2.89 12.55

Reports Covered

Stock Research & News

View All

Profile

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Microbot Medical Inc

288 Grove Street, Braintree, MA, United States, 02184

Key Executives

Name Title Year Born
Mr. Harel Gadot Co-Founder, Pres, CEO & Chairman 1973
Mr. Yoseph Bornstein CO-Founder & Independent Director 1959
Dr. Simon Sharon MBA, MSc CTO & GM 1960
Dr. Eyal Morag M.D. Chief Medical Officer & Member of Scientific Advisory Board 1965
Prof. Moshe Shoham D.Sc. Co-Founder, Scientific Director & Chairman of Scientific Advisory Board 1952
Ms. Rachel Vaknin Chief Financial Officer 1979
Mr. Harel Gadot Co-Founder, President, CEO & Chairman 1973
Mr. Yoseph Bornstein Co-Founder & Independent Director 1959
Ms. Rachel Vaknin Chief Financial Officer 1980
Dr. Simon Sharon MBA, MSc CTO & GM of Microbot Israel 1961

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions